Back to search

Hansa Biopharma Limited

08361712

active
Private Limited Company
england wales
Companies House
Health Score
75 / 100

Some Concerns

25/30
Filing
10/30
Financial
40/40
Risk
  • No accounts filed in last 18 months (-5)
  • Going concern doubt noted in accounts (-10)

Details

ASHCOMBE COURT, GODALMING, GU7 1LQ
Incorporated 15/01/2013

Compliance

Last accounts

31/12/2024

small

Next accounts due

30/09/2026

On track

Confirmation statement

Last: 15/01/2026

Due 29/01/2027

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Christina Sofie Sjã–Strã–M

director · Since 28/02/2024

GROUP ACCOUNTING MANAGER

SWEDISH · SWEDE · Age 49

Soren Hoffmann

director · Since 05/07/2024

LAWYER

DANISH · DENMARK · Age 59

Persons with Significant Control

Former PSCs

Dr Matthew David Max Crispin

Ceased 19/07/2016

Hansa Biopharma Ab

Ceased 19/07/2016

CompanyRankvs 1463+ SIC 72110 peers
47

Financial strength37th percentile among SIC peers · 9/25
Employees22th percentile among SIC peers · 3/15
LiquidityCurrent ratio 1.96× · 16/20
Longevity14 years trading (max 15) · 14/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10
Show leaderboard
1Charles River U.K. Limited
90
2Werfen Limited
90
3Biopharma Process Systems Limited
90
4Theradex (Europe) Limited
90
5Spicer Consulting Limited
90
6Exmoor Pharma Concepts Limited
90
7Ubc Late Stage (Uk) Limited
90
8Wuxi Apptec Uk Ltd
90
9Cenobiologics Ltd
90
10Ccm Technologies Limited
90
1463Hansa Biopharma Limited
52
How is this score calculated?
Financial strength9/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees3/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity16/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity14/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

debt financing. However if sufficient financing is not arranged by Hansa Biopharma AB there is a material uncertainty that may cast significant doubt on the company's ability to continue as a going concern. 1.3 Intangible fixed assets other than goodwill Intangible assets relate to patents acquired. Amortisation is recognised so as to write off the cost or valuation of assets less their re

Key FinancialsYear ending 31/12/2024

Net Worth

£10

Balance sheet strength

Cash

£50k

Cash in the bank

Net Current Assets

£282k

Working capital

Current Assets

£577k

Current Liabilities

£294k

Debtors

£527k

Profit After Tax

-£39k

0avg. employees

Tax at Year End

Corp tax£16k

Balance Sheet

Intangible assets£2k
Assets less current liabilities£284k
Prepared with CCH Software

EstimatesDerived

YearCurrent Ratio
20241.96

Derived from filed accounts. Not audited figures.